Published in J Clin Endocrinol Metab on July 01, 1992
Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol (1970) 5.61
Characterization of saccharolytic nonfermentative bacteria associated with man. Can J Microbiol (1970) 5.07
Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med (1999) 3.49
Insulin resistance in microvascular angina (syndrome X) Lancet (1993) 3.02
Nonfermentative bacilli associated with man. II. Detection and identification. Am J Clin Pathol (1970) 2.69
Inhibition of insulin secretion by somatostatin. Lancet (1973) 2.58
Salient features of nonsaccharolytic and weakly saccharolytic nonfermentative rods. Can J Microbiol (1970) 2.50
Operative versus nonoperative treatment of Achilles tendon rupture. A prospective randomized study and review of the literature. Am J Sports Med (1994) 2.41
Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes (1997) 2.00
Decreased regional blood flow in patients with acromegaly. Clin Endocrinol (Oxf) (1998) 1.99
Finger-length ratios and sexual orientation. Nature (2000) 1.67
Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. J Clin Invest (2000) 1.66
Diabetes, diabetic angiopathy, and growth hormone. Lancet (1970) 1.56
Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. Arch Intern Med (1997) 1.56
In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide. Eur J Endocrinol (1995) 1.53
Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature (1968) 1.49
The metabolic effects of quinine in children with severe and complicated Plasmodium falciparum malaria in Dar es Salaam. Trans R Soc Trop Med Hyg (1992) 1.44
Sustained reduction of exercise perfusion defect extent and severity with isosorbide mononitrate (Imdur) as demonstrated by means of technetium 99m sestamibi. J Nucl Cardiol (2000) 1.40
Effects of heparin on renal morphology and albuminuria in experimental diabetes. Am J Physiol (1996) 1.40
Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clin Endocrinol (Oxf) (1993) 1.40
Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children. Acta Endocrinol (Copenh) (1983) 1.37
Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol (1997) 1.31
Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab (2005) 1.31
Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care (1995) 1.26
Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev (1999) 1.26
Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltimore) (1994) 1.24
Synthesis of 125I monolabelled 3, 5, 3'-triiodothyronine and thyroxine of maximum specific activity for radioimmunoassay. Scand J Clin Lab Invest (1973) 1.22
Free insulin-like growth factors in human obesity. Metabolism (1995) 1.20
Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol (1999) 1.19
Vibratory perception during ischaemia in uraemic patients and in subjects with mild carbohydrate intolerance. J Neurol Neurosurg Psychiatry (1969) 1.16
Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group. J Clin Endocrinol Metab (1990) 1.15
Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol (1990) 1.15
The relationship between endogenous serum insulin concentration and glucose uptake in the forearm muscles of nondiabetics. J Clin Invest (1968) 1.14
Kinetics of white blood cell staining by intravascular administration of rhodamine 6G. Int J Microcirc Clin Exp (1996) 1.12
Adjacent tissues (cartilage, bone) affect the functional integration of engineered calf cartilage in vitro. Osteoarthritis Cartilage (2005) 1.12
Lipid metabolites and nitrogen balance after abdominal surgery in man. Br J Surg (1979) 1.08
Disodium cromoglycate (Lomudal) in the treatment of hay fever. Acta Allergol (1973) 1.08
Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul (1995) 1.08
Plasma disappearance rate of injected human insulin in juvenile diabetic, maturity-onset diabetic and nondiabetic subjects. Diabetes (1969) 1.07
Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children. Acta Endocrinol (Copenh) (1983) 1.05
Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours. Clin Pharmacokinet (1993) 1.04
The antigens of Mycobacterium tuberculosis. Protein fractions from cytoplasm and culture filtrate. Am Rev Respir Dis (1968) 1.03
Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut (1992) 1.02
Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med (1993) 1.02
The effect of vasopressin infusion on glucose metabolism in man. Clin Endocrinol (Oxf) (1985) 1.02
Effect of somatostatin analog octreotide on human sphincter of Oddi. Dig Dis Sci (1992) 1.02
Oxygen, nitric oxide and articular cartilage. Eur Cell Mater (2007) 1.01
Characterisation of somatostatin release from the pancreas: the role of calcium and acetylcholine. Diabetologia (1979) 1.01
Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients. Metabolism (1996) 0.99
Some actions of growth hormone release inhibiting factor. Br Med J (1973) 0.98
Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2007) 0.98
Septoplasty and compensatory inferior turbinate hypertrophy: a randomized study evaluated by acoustic rhinometry. J Laryngol Otol (1993) 0.97
Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett (1994) 0.97
X-ray examination and sinoscopy in maxillary sinus disease. Acta Otolaryngol (1972) 0.96
Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab (1992) 0.95
Fracture of the lunate bone. Hand (1982) 0.95
Fifteen cases of Pendred's syndrome. Congenital deafness and sporadic goiter. Arch Otolaryngol (1972) 0.94
Low cerebrospinal fluid somatostatin in Parkinson disease: an irreversible abnormality. Neurology (1982) 0.94
The effect of subcutaneous infusion versus subcutaneous injections of a somatostatin analogue (SMS 201-995) on the diurnal GH profile in acromegaly. Acta Endocrinol (Copenh) (1987) 0.93
The Mondini type of cochlear malformation. A survey of the literature. Arch Otolaryngol (1972) 0.93
Correlation between blood glucose concentration in diabetics and noninvasively measured tissue optical scattering coefficient. Opt Lett (1997) 0.93
Plasma insulin during remission in juvenile diabetes mellitus. Br Med J (1969) 0.93
Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest (1981) 0.93
A new sample-processing unit for the fluorescent microsphere method. Am J Physiol (1999) 0.93
Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia (1988) 0.93
Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders. Clin Ther (2000) 0.92
Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia. Diabetologia (1998) 0.92
Characterization and prevention of phototoxic effects in intravital fluorescence microscopy in the hamster dorsal skinfold model. Langenbecks Arch Surg (2000) 0.92
Hyperkalemic periodic paralysis. Relationships between changes in plasma water, electrolytes, insulin and catecholamines during attacks. Scand J Clin Lab Invest (1980) 0.91
Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study. Dan Med Bull (1988) 0.91
Ruptured fibular ankle ligament: plaster or Pliton brace? Br J Sports Med (1984) 0.91
Surgical treatment of Zenker's diverticulum. J Laryngol Otol (1990) 0.91
Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia (1990) 0.90
Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of the literature. Neuroimmunomodulation (1998) 0.90
Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia (1992) 0.89
Metabolic abnormalities in children of non-insulin dependent diabetics. Br Med J (Clin Res Ed) (1986) 0.89
The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas). Diabetologia (1982) 0.89
The presence of rheumatoid factor in sera from anti-HCV positive blood donors interferes with the detection of HCV-specific IgM. Trent HCV Study Group. J Hepatol (1996) 0.88
Effects of dextran on microvascular ischemia-reperfusion injury in striated muscle. Am J Physiol (1997) 0.88
Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 1. General principles. Neuroimmunomodulation (1998) 0.88
Wegener's granulomatosis. Long-term results of treatment. Ann Otol Rhinol Laryngol (1981) 0.88
Characterization of bacteria by their degradation of amino acids. Appl Microbiol (1968) 0.88
The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps. Clin Otolaryngol Allied Sci (1993) 0.88
In vivo monitoring of microvessels in skin flaps: introduction of a novel technique. Microsurgery (2001) 0.88
Streptozotocin diabetes: a glucoreceptor dysfunction affecting D cells as well as B and A cells. Diabetologia (1979) 0.88
Dopamine blockade inhibits starvation ketosis in man. Clin Endocrinol (Oxf) (1983) 0.88
Thyroid carcinoma in Pendred's syndrome. J Laryngol Otol (1978) 0.87
Sinoscopical biopsy in maxillary sinusitis. Acta Otolaryngol (1974) 0.87
Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int (1999) 0.87
Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Ann Intern Med (1990) 0.87
Role of fixation in the treatment of nasal fractures. Clin Otolaryngol Allied Sci (1983) 0.87
Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J Clin Endocrinol Metab (1999) 0.87
Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur J Pediatr (1994) 0.87
Hormonal and metabolic changes in hepatic cirrhosis. Horm Metab Res (1982) 0.87
Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab (1990) 0.87
Characteristics of patients with seasonal allergic rhinitis and concomitant asthma. Clin Exp Allergy (2004) 0.86